LnK Anterior Cervical Plate System

K143279 · L&K BIOMED Co., Ltd. · KWQ · Mar 20, 2015 · Orthopedic

Device Facts

• Record ID: K143279
• Device Name: LnK Anterior Cervical Plate System
• Applicant: L&K BIOMED Co., Ltd.
• Product Code: KWQ · Orthopedic
• Decision Date: Mar 20, 2015
• Decision: SESE
• Submission Type: Special
• Regulation: 21 CFR 888.3060
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The LnK Anterior Cervical Plate System is intended for anterior screw fixation to the cervical spine (C2-C7). The System is indicated for use in the immobilization and stabilization of the spine as an adjunct to fusions in patients with: - degenerative disc disease (as defined by neck pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), - spondylolisthesis, - trauma (i.e. fractures or dislocations), - tumors, - deformity (defined as kyphosis, lordosis, or scoliosis), - pseudoarthrosis. - failed previous fusion, - spinal stenosis.

Device Story

The LnK Anterior Cervical Plate System is a spinal fixation device consisting of titanium alloy plates and screws. It is used by surgeons in an operating room setting to provide immobilization and stabilization of the cervical spine (C2-C7) as an adjunct to fusion procedures. The system is implanted anteriorly, with plates secured to the spine using a minimum of four self-tapping, self-drilling screws per plate. By providing rigid fixation, the device facilitates spinal fusion, which can alleviate pain and restore stability in patients suffering from degenerative, traumatic, or structural spinal conditions. The system is provided non-sterile and requires sterilization before use.

Clinical Evidence

Bench testing only. Static compression bending, tension, torsion, and dynamic compression bending were performed according to ASTM F1717 on a worst-case cervical plate construct to demonstrate substantial equivalence.

Technological Characteristics

Materials: Titanium alloy Ti-6Al-4V ELI (ASTM F136). Components: Plates (1-4 level configurations, 13-97mm) and 3.5mm/4.0mm diameter self-tapping/self-drilling screws. Energy source: None (mechanical). Sterilization: Provided non-sterile.

Indications for Use

Indicated for patients requiring cervical spine (C2-C7) immobilization and stabilization as an adjunct to fusion. Conditions include degenerative disc disease, spondylolisthesis, trauma (fractures/dislocations), tumors, deformity (kyphosis, lordosis, scoliosis), pseudoarthrosis, failed previous fusion, and spinal stenosis.

Regulatory Classification

Identification

A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.

Predicate Devices

• LnK Anterior Cervical Plate System (K113509)

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle or bird with three profiles of human faces incorporated into its design. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the bird symbol.

Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002

March 20, 2015

L&K Biomed Company, Limited Ms. Yerim An #201, 202 16-25, Dongbaekjungang-ro 16 beon-gil Giheung-gu, Yongin-si Gyeonggi-do, 446-916 Republic of Korea

Re: K143279

Trade/Device Name: LnK Anterior Cervical Plate System Regulation Number: 21 CFR 888.3060 Regulation Name: Spinal intervertebral body fixation orthosis Regulatory Class: Class II Product Code: KWQ Dated: February 13, 2015 Received: February 18, 2015

Dear Ms. An:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set

{1}------------------------------------------------

Page 2 - Yerim An

forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to

http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.

You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number [phone] or [phone] or at its Internet address

http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.

Sincerely yours.

# Lori A. Wiggins -S

for Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

# Indications for Use

510(k) Number (if known) K143279

### Device Name

LnK Anterior Cervical Plate System

### Indications for Use (Describe)

The LnK Anterior Cervical Plate System is intended for anterior screw fixation to the cervical spine (C2-C7). The System is indicated for use in the immobilization and stabilization of the spine as an adjunct to fusions in patients with:

- · degenerative disc disease (as defined by neck pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies),
- · spondylolisthesis,
- · trauma (i.e. fractures or dislocations),
- · tumors,
- · deformity (defined as kyphosis, lordosis, or scoliosis),
- · pseudoarthrosis.
- · failed previous fusion,
- · spinal stenosis.

| Type of Use (Select one or both, as applicable) |
|-------------------------------------------------|
|-------------------------------------------------|

| <div> <span style="font-size: 20px;">☑</span> <span>Residential Use (Applicable if OFF-Highway Vehicle is Driven on Private Property)</span> </div> |
|-----------------------------------------------------------------------------------------------------------------------------------------------------|
| <div> <span style="font-size: 20px;">☐</span> <span>Other Use (Applicable if OFF-Highway Vehicle is Driven on Public Lands)</span> </div> |

|X | Prescription Use (Part 21 CFR 801 Subpart D)

| | Over-The-Counter Use (21 CFR 801 Subpart C)

### CONTINUE ON A SEPARATE PAGE IF NEEDED.

This section applies only to requirements of the Paperwork Reduction Act of 1995.

### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.*

The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:

> Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov

"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."

{3}------------------------------------------------

# 510(k) SUMMARY

The following 510(k) summary is being submitted as required by 21 CFR 807.92(a):

| 1. | Submitter: | L&K BIOMED Co., Ltd.<br>#201, 202 16-25, Dongbaekjungang-ro 16 beon-gil<br>Giheung-gu, Yongin-si, Gyeonggi-do, 446-916,<br>Korea<br>Phone. [phone]<br>FAX .[phone] |
|----|-----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| | Contact Person: | Yerim An |
| | Date prepared: | February 13, 2015 |

#### Device Identification 2.

| Trade Name | LnK Anterior Cervical Plate System |
|---------------------|-------------------------------------------------------------------|
| Common Name | Anterior Cervical Plate |
| Product Code | KWQ |
| Classification Name | Spinal Intervertebral Body Fixation Orthosis<br>(21 CFR 888.3060) |

#### Predicate or legally marketed devices which are substantially equivalent 3.

L&K Biomed: LnK Anterior Cervical Plate System (K113509) (Primary) .

#### Description of the Device 4.

The LnK Anterior Cervical Plate System is composed of plates and screws which are made from titanium alloy Ti-6A1-4V ELI (ASTM F136). These plates attach to the anterior cervical spine with a minimum of four screws per plate. The plates are offered in one-level, two-level, three-level and four-level fusion configurations (13~97mm). The plate screws are 3.5mm and 4.0mm diameter head screws. They are self-tapping and selfdrilling threaded. All implants are provided non-sterile.

{4}------------------------------------------------

#### ર. Intended use

The LnK Anterior Cervical Plate System is intended for anterior screw fixation to the cervical spine (C2-C7). The System is indicated for use in the immobilization and stabilization of the spine as an adjunct to fusions in patients with:

- degenerative disc disease (as defined by neck pain of discogenic origin with ● degeneration of the disc confirmed by patient history and radiographic studies),
- spondylolisthesis, .
- . trauma (i.e. fractures or dislocations),
- . tumors.
- deformity (defined as kyphosis, lordosis, or scoliosis),
- pseudoarthrosis. ●
- failed previous fusion, ●
- spinal stenosis.

### Comparison of the technology characteristics of the device to predicate and 6. legally marketed devices

There are no significant differences between the additional size of LnK Anterior Cervical Plate System and other systems currently being marketed. It is substantially equivalent to these other devices in design, function and intended use.

#### 7. Performance Data

Static compression bending, tension, torsion and dynamic compression bending were performed according to ASTM F1717 on a worst-case, cervical plate construct. These data demonstrate substantial equivalence in terms of performance bench testing.

#### 8. Conclusion

The additional size of Anterior Cervical Plate System is substantially equivalent to the devices referenced above and is therefore safe and effective for its intended use.